9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

Launched by UNIVERSITY HOSPITAL, GHENT · Aug 27, 2019

Keywords

ClinConnect Summary

The 9000 URETHRA STUDY is looking at a treatment called urethroplasty for a condition known as urethral stricture disease, which is when the urethra (the tube that carries urine from the bladder) becomes narrowed. This study is important because it aims to gather new information about how effective urethroplasty is compared to other treatments, like endoscopic procedures, to ensure that everyone, including men, women, transgender individuals, and children, can benefit from the best possible care.

To participate in this study, individuals need to be at least 6 years old and must be willing to sign a consent form agreeing to take part. If someone turns 18 during the study, they will need to sign a new consent form. Participants can expect to contribute to valuable research that could help improve treatment options for themselves and others with similar conditions. The study is currently recruiting, which means there are opportunities for eligible individuals to join and help shape future treatment approaches.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations.
• • Patient age ≥ 6 years.
• • If a patient reaches the age of 18 years, he or she will have to provide a new voluntarily signed written informed consent. All patients reaching the age of 18 years will be contacted by the Principal Investigator or Subinvestigator to provide a new voluntarily signed written informed consent.
• Exclusion Criteria:
• • - Absence of signed written informed consent and thus a patient unwilling to participate.